| Description | Their American company are investigating a new antibiotic, erythromycin - considered worthy of trial against infections produced by gram positive bacteria and certain other organisms, including rickettsiae and possibly some viruses - resembles penicillin but includes many additional organisms in the spectra - comments on resistance and dosage. |